Do you want to read an article? Please log in or register.
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD
Further Publications
Indications
Related content
Hepatology
Association between longitudinal weight change and clinical outcome in individuals with MASLD
Hepatology
Shi Y, Zhou R, Kim SU, Yip TC, Tsochatzis E, Petta S, Nakajima A, Hagström H, Bugianesi E, Chan WK, Boursier J, Goh BG, Sanyal AJ, Romero-Gomez M, Calleja JL, Lédinghen V, Newsome PN, Fan JG, Lai M, Castéra L, Fournier-Poizat C, Lee HW, Wong GL, Pennisi G, Yoneda M, Shang Y, Armandi A, de Saint-Loup M, Canivet CM, Teh KK, Asgharpour A, Gallego-Durán R, Llop E, Lara-Romero C, Sau-Wai Chan M, Zoncape M, Lin H, Liu WY, Targher G, Byrne CD, Wong VW, Zheng MH, VCTE-Prognosis Study Group
doi: 10.1097/HEP.0000000000001557
Inflammatory Bowel Disease
Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype
J Crohns Colitis
Pertsinidou E, Salomon B, Bergemalm D, Salihovic S, Hedin CRH, Ling Lundström M, Keita ÅV, Magnusson MK, Eriksson C, Bengtson MB, Grännö O, Aabrekk TB, Movérare R, Rydell N, Ekoff H, Rönnelid J, BIO-IBD consortium, D'Amato M, Detlie TE, Huppertz-Hauss G, Opheim R, Ricanek P, Kristensen VA, Öhman L, Söderholm JD, Kruse R, Lindqvist CM, Carlson M, Repsilber D, Høivik ML, Halfvarson J
doi: 10.1093/ecco-jcc/jjaf062
Hepatology
Impact of MASLD and associated comorbidities on Cognitive and Health-related Quality of Life outcomes in a Mixed MASLD-T2DM Cohort
Am J Gastroenterol
Perez-Diaz-Del-Campo N, Castelnuovo G, Ferro A, Caviglia GP, Rosso C, Dileo E, Guariglia M, Armandi A, Saba F, Saracco GM, Barutta F, Beccuti G, Gruden G, Younossi ZM, Bugianesi E
doi: 10.14309/ajg.0000000000003594
Hepatology
High inherited risk predicts age-associated increases in fibrosis in patients with MASLD
J Hepatol
Díaz LA, Alazawi W, Agrawal S, Arab JP, Arrese M, Idalsoaga F, Barreyro FJ, Gadano A, Marciano S, Morales JM, Villela-Nogueira C, Leite N, Couto CA, Theodoro R, Joyner de Sousa Dias Monteiro M, Oliveira CP, Pessoa MG, Alvares-da-Silva MR, Madamba E, Bettencourt R, Richards LM, Majithia AR, Khera AV, Loomba R, Ajmera V
doi: 10.1016/j.jhep.2025.04.035
Gallbladder and Biliary Diseases
Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis
J Hepatol
Wong YJ, Lam L, Soret PA, Lemoinne S, Hansen B, Hirschfield G, Gulamhusein A, Lytvyak E, Pares A, Olivas I, Londono MC, Rogriguez-Tajes S, Eaton JE, Osman KT, Schramm C, Sebode M, Lohse AW, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Floreani A, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Sobenko N, Villamil AM, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Bruns T, Große K, Wetten A, Dyson JK, Jones D, Levy C, Tanaka A, Dumortier J, Pageaux GP, de Lédinghen V, Carrat F, Chazouillères O, Corpechot C, Montano-Loza AJ, Global & ERN Rare-Liver PBC Study Groups
doi: 10.1016/j.jhep.2025.09.024
Hepatology
Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes
Hepatology
Newton KP, Jayasekera D, Blackford AL, Behling C, Wilson LA, Fishbein MH, Molleston JP, Xanthakos SA, Vos MB, Schwimmer JB, NASH CRN
doi: 10.1097/HEP.0000000000001216
Hepatology
Change in cT1 following interventions in MASLD: A systematic review and meta-analysis
Clin Gastroenterol Hepatol
Andersson A, Loomba R, Beyer C, Mouchti S, Vuppalanchi R, Harisinghani M, Ajaz S, Dinani A, Banerjee A, Muthiah M, Dennis A, Pansini M
doi: 10.1016/j.cgh.2025.03.003
Inflammatory Bowel Disease
Longitudinal Profiles of Fecal Calprotectin and C-Reactive Protein in Relation to Outcomes in Crohn's Disease Patients on Infliximab
J Crohns Colitis
Magro F, Domingues B, Estevinho MM, Patita M, Arroja B, Lago P, Rosa I, de Sousa HT, Ministro P, Mocanu I, Vieira A, Castela J, Moleiro J, Roseira J, Cancela E, Sousa P, Portela F, Correia L, Fernandes S, Dias CC, Dias S, Peyrin-Biroulet L, Danese S, Santiago M, GEDII
doi: 10.1093/ecco-jcc/jjaf120
Hepatology
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study
Lancet Gastroenterol Hepatol
Lindvig KP, Thorhauge KH, Hansen JK, Kjærgaard M, Hansen CD, Johansen S, Lyngbeck E, Israelsen M, Andersen P, Bech KT, Torp N, Schnefeld HL, Detlefsen S, Möller S, Graupera I, Trelle MB, Antonsen S, Harris R, Kårhus LL, Bjørnsbo KS, Brøns C, Hansen T, Geier A, Wedemeyer H, Zeuzem S, Schattenberg JM, Ginès P, Guha IN, Krag A, Thiele M
doi: 10.1016/S2468-1253(24)00274-7